"Partners:
Both have been having talks with large pharmas. anp are certainly being noticed and are probably ahead on this score"
-----
Unless a commercial partner offers a crazy very sweet deal there is absolutely no need for NEU to license NNZ-2566 given the DoD is 99.999% guaranteed to fund half of the Phase III trial and NDA application costs.
All without taking a cent from future non-military sales.
neu v anp, page-2
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$19.86 |
Change
0.560(2.90%) |
Mkt cap ! $2.538B | |||
| Open | High | Low | Value | Volume |
| $19.80 | $20.00 | $19.40 | $3.777M | 191.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1060 | $19.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $19.87 | 209 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |